Home › NDC Lookup › RxCUI directory › RxCUI 1043075

Petrolatum 300 MG/ML Topical Cream — RxCUI 1043075

RxNorm drug concept · Semantic clinical drug
RxCUI 1043075 Semantic clinical drug · SCD ● Current RxNorm concept 11 FDA products 18 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1043075
Official namePetrolatum 300 MG/ML Topical Cream
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspetrolatum 30 % Topical Cream
FDA products mapped11
Package NDCs mapped18
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Petrolatum 300 MG/ML Topical Cream Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Petrolatum 300 MG/ML Topical Cream RxCUI 1043075

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Petrolatum 8091
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Vaseline 224932
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Petrolatum Topical Cream 377790
    • Petrolatum Topical Product 1156409
    • Petrolatum Topical Cream [Vaseline] 1045488
    • Vaseline Topical Product 1187580
    • Topical Cream 316982
    • Topical Product 1151122
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Petrolatum 300 MG/ML SCDC · 343356
  • Petrolatum Topical Cream SCDF · 377790
  • Petrolatum Topical Product SCDG · 1156409

Brand-Name Concepts

  • Petrolatum 300 MG/ML Topical Cream [Vaseline] SBD · 1045489
  • Petrolatum 300 MG/ML [Vaseline] SBDC · 1045487
  • Petrolatum Topical Cream [Vaseline] SBDF · 1045488
  • Vaseline Topical Product SBDG · 1187580
  • Vaseline BN · 224932

📦 FDA Products & Package NDCs

11 products · 18 package NDCs
18 package NDCs map to RxCUI 1043075 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
33992-0498-01 85 g in 1 TUBE (33992-0498-1) Petrolatum Greenbrier International, Inc. 2019-05-17
33992-0499-01 85 g in 1 TUBE (33992-0499-1) Petrolatum Greenbrier International, Inc. 2019-02-04
51824-0083-03 85 g in 1 TUBE (51824-083-03) CareALL Creamy Cocoa Butter Petroleum Jelly New World Imports, Inc 2021-02-01
57337-0039-01 198 g in 1 BOTTLE (57337-039-01) XtraCare Creamy Petroleum Jelly Cocoa Butter Enriched Rejoice International 2014-01-24
57337-0040-01 198 g in 1 BOTTLE (57337-040-01) XtraCare Creamy Petroleum Jelly Vitamin E enriched Rejoice International 2014-01-24
64942-1401-01 127 g in 1 TUBE (64942-1401-1) Vaseline Intensive Care Deep Moisture Conopco Inc. d/b/a Unilever 2015-10-01
64942-1401-02 255 g in 1 TUBE (64942-1401-2) Vaseline Intensive Care Deep Moisture Conopco Inc. d/b/a Unilever 2015-10-01
69981-0194-01 30 mL in 1 JAR (69981-194-01) CUREFINI Skin Protection Cream Rev Pharma Corp 2021-07-12
69981-0194-02 60 mL in 1 JAR (69981-194-02) CUREFINI Skin Protection Cream Rev Pharma Corp 2021-07-12
69981-0194-04 120 mL in 1 JAR (69981-194-04) CUREFINI Skin Protection Cream Rev Pharma Corp 2021-07-12
69981-0194-08 240 mL in 1 JAR (69981-194-08) CUREFINI Skin Protection Cream Rev Pharma Corp 2021-07-12
69981-0729-01 1 BOTTLE, PLASTIC in 1 BOX (69981-729-01) / 177.441 mL in 1... Curefini Dermal Rev Pharma Corp. 2017-02-08
69981-0729-03 90 mL in 1 TUBE (69981-729-03) Curefini Dermal Rev Pharma Corp. 2018-11-01
79974-0203-02 59.147 mL in 1 TUBE (79974-203-02) CUREFINI Miramar Cosmetics, Inc DBA Miramar Lab 2023-04-24
79974-0203-04 118.294 mL in 1 TUBE (79974-203-04) CUREFINI Miramar Cosmetics, Inc DBA Miramar Lab 2023-04-24
79974-0203-06 177.441 mL in 1 TUBE (79974-203-06) CUREFINI Miramar Cosmetics, Inc DBA Miramar Lab 2023-04-24
80489-0901-01 85 g in 1 TUBE (80489-901-01) Drs. Pharmacy Creamy Petroleum Jelly OL PHARMA TECH, LLC Drs PHARMACY 2026-06-16
80489-0902-01 85 g in 1 TUBE (80489-902-01) Drs. Pharmacy Creamy Cocoa Butter Petroleum Jelly OL PHARMA TECH, LLC Drs PHARMACY 2026-06-16
Observed labelers: Rev Pharma Corp (4) · Miramar Cosmetics, Inc DBA Miramar Lab (3) · Conopco Inc. d/b/a Unilever (2) · Greenbrier International, Inc. (2) · OL PHARMA TECH, LLC Drs PHARMACY (2) · Rejoice International (2) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.